1. Home
  2. FATE vs TRC Comparison

FATE vs TRC Comparison

Compare FATE & TRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • TRC
  • Stock Information
  • Founded
  • FATE 2007
  • TRC 1843
  • Country
  • FATE United States
  • TRC United States
  • Employees
  • FATE N/A
  • TRC N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • TRC Real Estate
  • Sector
  • FATE Health Care
  • TRC Finance
  • Exchange
  • FATE Nasdaq
  • TRC Nasdaq
  • Market Cap
  • FATE 406.5M
  • TRC 431.4M
  • IPO Year
  • FATE 2013
  • TRC N/A
  • Fundamental
  • Price
  • FATE $1.27
  • TRC $16.13
  • Analyst Decision
  • FATE Hold
  • TRC
  • Analyst Count
  • FATE 10
  • TRC 0
  • Target Price
  • FATE $6.75
  • TRC N/A
  • AVG Volume (30 Days)
  • FATE 3.2M
  • TRC 105.5K
  • Earning Date
  • FATE 02-24-2025
  • TRC 03-05-2025
  • Dividend Yield
  • FATE N/A
  • TRC N/A
  • EPS Growth
  • FATE N/A
  • TRC N/A
  • EPS
  • FATE N/A
  • TRC N/A
  • Revenue
  • FATE $13,447,000.00
  • TRC $40,118,000.00
  • Revenue This Year
  • FATE N/A
  • TRC N/A
  • Revenue Next Year
  • FATE N/A
  • TRC $16.57
  • P/E Ratio
  • FATE N/A
  • TRC N/A
  • Revenue Growth
  • FATE N/A
  • TRC N/A
  • 52 Week Low
  • FATE $1.04
  • TRC $14.71
  • 52 Week High
  • FATE $8.83
  • TRC $19.82
  • Technical
  • Relative Strength Index (RSI)
  • FATE 31.94
  • TRC 56.13
  • Support Level
  • FATE $1.22
  • TRC $15.00
  • Resistance Level
  • FATE $1.36
  • TRC $16.45
  • Average True Range (ATR)
  • FATE 0.15
  • TRC 0.37
  • MACD
  • FATE -0.02
  • TRC 0.07
  • Stochastic Oscillator
  • FATE 24.21
  • TRC 77.93

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About TRC Tejon Ranch Co

Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely commercial/industrial real estate development, resort/residential real estate development, mineral resources, farming, and ranch operations.

Share on Social Networks: